Article Versions Notes

Fortún J, Gómez-García de la Pedrosa E, Martínez-Lorca A, Paredes P, Martín-Dávila P, Gómez-López A, Buitrago MJ, López-Jiménez J, Gioia F, Escudero R, et al. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis. Journal of Fungi. 2024; 10(3):191. https://doi.org/10.3390/jof10030191

Fortún, Jesús, Elia Gómez-García de la Pedrosa, Alberto Martínez-Lorca, Patricia Paredes, Pilar Martín-Dávila, Alicia Gómez-López, María José Buitrago, Javier López-Jiménez, Francesca Gioia, Rosa Escudero, and et al. 2024. "A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis" Journal of Fungi 10, no. 3: 191. https://doi.org/10.3390/jof10030191

Fortún, J., Gómez-García de la Pedrosa, E., Martínez-Lorca, A., Paredes, P., Martín-Dávila, P., Gómez-López, A., Buitrago, M. J., López-Jiménez, J., Gioia, F., Escudero, R., Alvarez-Alvarez, M. E., Soriano, C., Moreno-García, J., San Miguel, D., Vicente, N., & Moreno, S. (2024). A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis. Journal of Fungi, 10(3), 191. https://doi.org/10.3390/jof10030191